Related by context. All words. (Click for frequent words.) 77 colorectal cancers 74 breast cancers 73 lung cancers 73 ovarian cancers 71 cancers 70 prostate cancers 69 bladder cancers 69 pancreatic cancers 68 colorectal cancer 67 cervical cancers 67 endometrial cancers 66 bowel cancers 65 uterine cancers 65 malignancies 64 colorectal cancer CRC 63 nonmelanoma skin cancers 63 esophageal cancers 63 gastric cancers 63 colon tumors 63 testicular cancers 62 ovarian cancer 62 gastrointestinal cancers 62 squamous cell carcinomas 62 adenocarcinomas 62 invasive breast cancer 61 malignancy 61 endometrial cancer 61 basal cell carcinomas 61 adenocarcinoma 61 adenomatous polyps 61 rectal cancers 61 carcinomas 61 thyroid cancers 61 pre cancerous growths 60 precursor lesions 60 colorectal tumors 60 neuroendocrine tumors 60 breast tumors 60 HNSCC 60 pre cancerous polyps 60 pre cancerous lesions 60 ovarian tumors 60 adenomas 60 adenoma 60 breast colon 60 breast carcinomas 60 precancerous lesions 60 rectal cancer 60 gastric cancer 59 lobular cancer 59 pancreatic lung 59 endometrial hyperplasia 59 colon breast 59 ductal cancer 59 squamous cell 59 precancers 59 serous ovarian cancer 59 mesotheliomas 59 colon cancer 59 BRCA2 mutations 59 lobular breast cancer 58 cervical cancer 58 advanced adenoma 58 lung tumors 58 benign growths 58 nonsmall cell lung cancer 58 uveal melanoma 58 osteosarcomas 58 tumors 58 BRCA1 mutations 58 breast ovarian 58 lobular carcinoma 58 gynecological cancers 58 atypical hyperplasia 58 colorectal polyps 58 oropharyngeal cancer 58 hereditary breast cancer 58 anal cancers 58 genes BRCA1 58 pleural mesothelioma 58 colorectal polyp 58 Colorectal cancers 57 skin cancers 57 melanomas 57 colorectal carcinoma 57 hepatocellular cancer 57 gynecologic cancers 57 cervical lesions 57 breast endometrial 57 familial pancreatic cancer 57 colorectal adenomas 57 advanced adenomas 57 epithelial tumors 57 hepatocellular carcinoma 57 malignant growths 57 prostate ovarian 57 familial ALS 57 prostate tumors 57 curable cancers 57 sarcomas 57 HPV infections 57 precancerous growths 57 colorectal 57 Colon polyps 57 invasive cervical cancers 57 malignant tumors 57 HER2 positive 57 melanoma 57 leukaemias 57 squamous cell lung cancer 57 hamartomas 57 basal cell skin 57 cervical breast 57 lung colorectal 57 metastases 57 carcinoma 57 medulloblastomas 57 APOL1 57 Metastases 56 HPV 56 systemic scleroderma 56 epithelial cancers 56 basal cell nevus syndrome 56 nonmelanoma skin cancer 56 Cancers 56 prostate breast 56 colon polyps 56 GISTs 56 squamous cell carcinoma 56 BRCA mutations 56 neuroblastoma tumors 56 gynecologic cancer 56 Polyps 56 pathogenic mutations 56 breast cancer 56 grade cervical intraepithelial 56 metastatic disease 56 neuroblastomas 56 colorectal gastric 56 HPV infection 56 liver metastases 56 ovarian breast 56 medullary thyroid cancer 56 benign polyps 56 invasive ductal carcinoma 56 premalignant 56 ductal carcinomas 56 lymphomas 56 invasive cervical cancer 56 carcinoid 56 lung cancer 56 ovarian lung 55 ovarian pancreatic 55 bowel polyps 55 HPV# 55 nasopharyngeal carcinoma 55 ependymomas 55 Renal cell carcinoma 55 breast cancer recurrence 55 metastatic cancer 55 NAFLD 55 BRCA deficient 55 metastatic colorectal 55 ALK mutations 55 basal cell carcinoma 55 Uterine cancer 55 intestinal polyps 55 atypical ductal hyperplasia 55 Basal cell 55 breast pancreatic 55 benign breast 55 oesophageal cancers 55 HNPCC 55 uterine ovarian 55 premalignant lesions 55 Squamous cell 55 Cholangiocarcinoma 55 pancreatic adenocarcinoma 55 malignant polyps 55 prostate cancer 55 metastatic tumors 55 invasive carcinoma 55 FGFR2 55 metastatic cancers 55 medulloblastoma 55 pancreatic prostate 55 prostate cancer CaP 55 Ovarian cancer 55 GBM tumors 55 adenomatous polyp 55 cell carcinoma 55 mutated KRAS gene 55 ALCL 55 oesophageal adenocarcinoma 55 Gastric cancer 55 Barrett esophagus 55 benign tumors 55 inherited mutations 55 seminoma 55 lung pancreatic 55 molecular abnormalities 55 EGFR mutation 55 lymph node metastases 55 leiomyomas 55 precancerous polyps 55 penile cancers 55 BRCA mutation 54 ductal breast cancer 54 cutaneous melanoma 54 hormone receptor positive 54 Colorectal cancer 54 lung adenocarcinoma 54 familial adenomatous polyposis 54 malignant pleural mesothelioma 54 vulvar cancer 54 Human papilloma virus 54 peritoneal carcinomatosis 54 squamous cell skin 54 situ LCIS 54 pre cancerous cells 54 Testicular cancer 54 esophageal tumors 54 pancreatic tumors 54 MSH2 54 breast cancer recurrences 54 microdeletions 54 prostate colon 54 chromosomal abnormalities 54 polyps 54 atypia 54 fibroadenomas 54 ductal lobular 54 Endometrial cancer 54 CMV disease 54 GIST tumors 54 renal cell carcinomas 54 colorectal breast 54 cervical carcinoma 54 BRCA1 54 seminomas 54 p# mutations 54 ADPKD 54 gene mutations 54 Basal cell carcinoma 54 metastatic melanomas 54 periodontitis 54 neoplasms 54 genital herpes infections 54 cancerous polyps 54 prostate adenocarcinoma 54 peritoneal cancer 54 leukemias 54 commonly mutated genes 54 sporadic ALS 54 melanoma tumors 54 glioma rarer 54 gynecologic malignancy 54 hereditary predisposition 54 Uterine fibroids 54 venous blood clots 54 Gliomas 54 axillary lymph nodes 54 mutated genes 54 digestive tract cancers 54 tumor suppressor genes 54 distant metastases 54 precancerous colon polyps 54 contralateral breast 54 Epstein Barr virus EBV 54 hepatocellular carcinoma HCC 54 TCF#L# 54 testicular tumors 54 cervical intraepithelial neoplasia 54 BRCA2 54 prostate pancreatic 54 basal cell cancer 54 colorectal neoplasms 54 bowel cancer 54 colo rectal cancer 54 invasive ductal 54 renal cell carcinoma 53 abnormal growths 53 malignant melanomas 53 ovarian colorectal 53 MALT lymphoma 53 distant metastasis 53 soft tissue sarcomas 53 micrometastases 53 HCV infection 53 BRAF gene 53 Bladder cancer 53 basal cell cancers 53 Papillary 53 neoplasias 53 esophageal squamous cell carcinoma 53 Acute lymphoblastic leukemia 53 ccRCC 53 Stomach cancer 53 neuroendocrine cancers 53 glioblastomas 53 spinal muscle atrophy 53 vaginal cancers 53 BRCA1 mutation carriers 53 NSCLC 53 K ras mutations 53 gene variants 53 colorectal neoplasia 53 Squamous cell carcinomas 53 malignant lesions 53 genetic variants associated 53 Brain metastases 53 tumor recurrence 53 Adenomas 53 metastatic lung cancer 53 basal cell carcinoma BCC 53 metastatic prostate cancer 53 endometrial carcinoma 53 EGFR inhibitors 53 colonic polyps 53 Helicobacter pylori infection 53 Glioblastoma 53 metastasis 53 CMV infection 53 HPV types 53 precancerous tumors 53 gene BRCA2 53 neovascular AMD 53 frequently benign tumor 53 meningiomas 53 squamous cell cancer 53 familial adenomatous polyposis FAP 53 HER2 positive cancers 53 colorectal adenoma 53 EGFR mutations 53 renal carcinoma 53 MGUS 53 breast cancer metastasis 53 squamous cell cancers 53 carcinoid cancer 53 PCa 53 carcinoid tumors 53 Tay Sachs thalassemia 53 acid secretion 53 K ras gene 53 metastatic lesions 53 breast lesions 53 B7 H3 53 Chronic myeloid leukemia 53 GSTM1 53 Hepatocellular carcinoma 53 essential thrombocythemia 53 precancer 53 metachronous 53 pre cancerous lesion 53 abnormal Pap 53 Recurrences 53 breast prostate 53 pharyngeal cancer 53 pancreatic ovarian 53 ductal adenocarcinoma 53 CYT# potent vascular disrupting 53 BRAF V#E 53 Li Fraumeni 53 myelofibrosis polycythemia vera 53 metastatic colon cancer 53 BRAF mutations 53 cancer 53 endometrial tumors 53 PCNSL 52 Basal cell carcinomas 52 Epithelial ovarian cancer 52 estrogen receptor negative 52 grade gliomas 52 colorectal bowel 52 neoplasia 52 Glioblastoma multiforme GBM 52 operable breast cancer 52 colorectal lung 52 BRCA1 gene 52 H. pylori infection 52 neuroendocrine carcinoma 52 PARP inhibition 52 B Cell Lymphoma 52 pancreatic colorectal 52 atherosclerotic lesions 52 detect precancerous lesions 52 hormone receptor negative 52 leukemia ALL 52 leukemias lymphomas 52 ovarian carcinoma 52 epithelial ovarian cancer 52 malignant neoplasm 52 lung colon 52 oesophageal cancer 52 gastrointestinal GI cancers 52 Li Fraumeni syndrome 52 lung prostate 52 BRCA1 BRCA2 52 Lung cancer 52 associated lymphoid tissue 52 glioblastoma 52 cancerdefine 52 CIN3 + 52 glioblastoma tumors 52 NKX2 52 Melanomas 52 untreated celiac disease 52 nasopharyngeal cancer 52 aneuploidies 52 precancerous cervical lesions 52 Helicobacter pylori H. pylori 52 GSTP1 52 breast cancer susceptibility genes 52 BRCA genes 52 precancerous cervical 52 HER2 positive breast cancer 52 PGDH 52 chlamydial infection 52 pancreatic colon 52 Hepatocellular Carcinoma HCC 52 benign proliferative breast 52 external genital lesions 52 mutated BRCA1 52 HER2 overexpression 52 subclinical hyperthyroidism 52 cetuximab Erbitux 52 leiomyosarcoma 52 hormone therapy estrogen 52 hypermethylation 52 genetic variant 52 paragangliomas 52 colon rectal cancer 52 cruciferous vegetables 52 chromosomal aberrations 52 uterine cancer 52 Her2 52 proliferative diabetic retinopathy 52 papillary renal cell carcinoma 52 adenoid cystic carcinoma 52 colon pancreas 52 breast uterine 52 Metastatic 52 prostate lung 52 prediabetes 52 colorectal pancreatic 52 lung adenocarcinomas 52 HCV infections 52 mutations 52 Human papillomavirus HPV 52 ductal carcinoma 52 aberrant methylation 52 faulty BRCA genes 52 pulmonary metastases 52 pre cancerous 52 adenomatous 52 chronic prostatitis 52 embryonal rhabdomyosarcoma 52 human papillomavirus HPV 52 MUC1 protein 52 EZH2 52 premalignant lesion 52 hyperplastic 52 colon prostate 52 breast colorectal 52 metastatic brain tumor 52 CIN2 + 52 promoter hypermethylation 52 FSGS 52 brain metastases 52 Peritoneal mesothelioma 52 vulvar cancers 52 cancerous lesions 52 GNAQ 52 follicular lymphoma 52 gastrointestinal stromal tumor 52 BRCA2 gene mutation 52 liver metastasis 52 Thyroid nodules 52 elevated CRP 52 oesophageal squamous cell carcinoma 52 thyroid nodules 52 lung carcinomas 52 pre malignant lesions 52 salpingo oophorectomy 52 polyp recurrence 52 uPAR 52 DCIS 52 IgA deficiency 52 gene mutation 51 postmenopausal breast cancer 51 skeletal metastases 51 Thyroid cancer 51 methylation markers 51 cardiovascular disease 51 LRP5 51 epithelial ovarian 51 medulloblastoma tumors 51 lipid abnormalities 51 liver cancer 51 ZNF# 51 osteoporotic fractures 51 gene fusions 51 tumor suppressor gene 51 metastatic adenocarcinoma 51 herpes infection 51 perimenopausal women 51 ischemic strokes 51 benign lesions 51 disease NAFLD 51 type 1diabetes 51 malignant mesothelioma 51 metastatic prostate 51 cholangiocarcinoma 51 situ DCIS 51 vaginal lesions 51 lymphatic tissue 51 gastric adenocarcinoma 51 astrocytomas 51 abnormal Pap smears 51 ApoE4 gene 51 Pancreatic neuroendocrine tumors 51 genetic mutations 51 NF1 51 abnormal pap smears 51 ovarian endometrial 51 metastatic 51 malignant gliomas 51 imatinib resistance 51 disease 51 testicular germ cell 51 cervix uteri 51 Genetic variants 51 mutated gene 51 BRCA2 carriers 51 squamous 51 HER2 51 Inflammatory breast cancer 51 elevated triglyceride levels 51 pituitary adenomas 51 Sjögren syndrome 51 darapladib 51 Malignant gliomas 51 breast carcinoma 51 germline mutations 51 distal colon cancer 51 angiosarcoma 51 FGFR2 gene 51 gastrointestinal stromal tumors 51 endostatin 51 Glioblastoma Multiforme GBM 51 oropharyngeal squamous cell carcinoma 51 acute leukemias 51 grade glioma 51 esophageal adenocarcinoma 51 Hashimoto thyroiditis 51 recurrent ovarian cancer 51 gene variation 51 colon pancreatic 51 Chronic pancreatitis 51 cell lung cancer 51 pituitary tumors 51 Bowel cancer 51 STAT4 51 Sjogren syndrome 51 intensive statin therapy 51 precancerous 51 cancerous tumors 51 Metastatic breast cancer 51 JAK2 mutation 51 CaP 51 gene variant 51 mammary tumors 51 MLH1 51 aneuploid cells 51 Adenocarcinoma 51 catheter angiography 51 cervical dysplasia 51 lung nodules 51 HbF 51 cell carcinomas 51 HLA B# 51 BRCA gene 51 neoplasm 51 colorectal tumor 51 cervical vulvar 51 T1DM 51 APOE e4 51 specific antigen 51 sentinel nodes 51 EBV infection 51 heart disease 51 prostate tumor 51 cervical neoplasia 51 anaplastic lymphoma kinase 51 malignant melanoma 51 breast ovary 51 KRAS mutation 51 AAT deficiency 51 bone metastasis 51 polyps growths 51 precancerous polyp 51 HER2 gene 51 undergone radical prostatectomy 51 choriocarcinoma 51 colorectal carcinomas 51 Malignant tumors 51 MTHFR 51 EUS FNA 51 BRCA2 mutation carriers 51 TGFBR1 * 6A 51 endometrial kidney 51 CIN2 51 endometrial 51 bacterial overgrowth 51 colon esophageal 51 metastatic HER2 positive 51 defective gene 51 ovarian carcinomas 51 Carcinoma 51 ocular toxicity 51 endocrine tumors 50 HER2 amplified 50 Glioblastomas 50 Zinc deficiency 50 cardio vascular disease 50 Wilms tumor 50 KIF6 gene 50 TP# mutations 50 homozygous familial hypercholesterolemia 50 laryngeal cancer 50 ABCB1 50 mtDNA mutations 50 endometrial ovarian 50 gallstone disease 50 MLL2 50 noncancerous 50 breast cervical 50 chlamydial infections 50 FTLD 50 grade cervical dysplasia 50 mammographically 50 respiratory viral infections 50 CIN3 50 obstructive coronary 50 Cell Lung Cancer 50 cyclin E 50 genital wart cases 50 colonoscopy sigmoidoscopy 50 BRAF mutation 50 differentiated thyroid 50 intravenous bisphosphonates 50 genetic variants 50 HER2 positive breast 50 synovial sarcoma 50 CDH1 50 postoperative pathology 50 premenopausal breast cancer 50 carcinoid tumor 50 Fatty Liver Disease 50 gestational diabetes 50 transthyretin amyloidosis 50 nonmelanoma 50 Cervical cancer 50 lobular carcinomas 50 gastrointestinal stromal tumors GISTs 50 locoregional recurrence 50 urothelial cancer 50 lipomas 50 progesterone receptor negative 50 dentinal hypersensitivity 50 alveolar rhabdomyosarcoma 50 cisplatin resistant 50 diffuse gastric 50 ovulatory infertility 50 PALB2 50 anaplastic 50 nonmetastatic 50 papillary thyroid cancer 50 prostate carcinomas 50 uterine tumors 50 Chronic myeloid leukemia CML 50 Haptoglobin 50 EGF receptors 50 invasive ductal breast cancer 50 #q# [001] 50 gene amplification 50 SOD1 50 colon lung 50 ependymoma 50 Esophageal cancer 50 abnormalities 50 narcolepsy cataplexy 50 malignant transformation 50 factor receptor EGFR 50 cell lymphomas 50 urothelial carcinoma 50 bladder ovarian 50 proximal colon 50 brain tumors 50 sickle cell cystic fibrosis 50 Acute myeloid leukemia 50 HER2 positive tumors 50 RAS mutations 50 neuroblastoma 50 hematologic malignancies 50 prostate cancer PCa 50 bladder prostate 50 genital ulcers 50 olaparib 50 GPC5 50 familial hypercholesterolemia 50 SORL1 50 androgen receptor AR 50 papillary RCC 50 EGFR gene 50 Tumours 50 mutation 50 Fibroid tumors 50 contralateral breast cancer 50 TTR amyloidosis 50 pancreatic bladder 50 BMPR2 50 Adjuvant chemotherapy 50 polycystic ovary syndrome PCOS 50 Digital Mammographic Imaging 50 somatic mutations 50 HPV genotypes 50 Peutz Jeghers syndrome 50 sCJD 50 PTEN protein 50 pheochromocytomas 50 Non Hodgkin lymphoma 50 aromatase 50 solid tumors 50 monogenic 50 beta catenin protein 50 sarcosine 50 OGG1 50 lung metastases 50 DCIS lesions 50 BRCA 50 H. pylori 50 HPVs 50 aneuploidy 50 Basal Cell 50 Squamous cell carcinoma 50 inflammatory bowel disease 50 neurodegenerative disorder 50 pre menopausal 50 recurrent metastatic 50 neuroblastoma tumor 50 Malignant Melanoma 50 pneumococcal strains 50 renal tumors 50 spontaneously regress 50 glandular tissue 50 LRRK2 gene 50 ASCUS 50 IDH1 50 prostate specific 50 mammary cancers 50 BRAF protein 50 antigen PSA 50 BRCA mutation carriers 50 Chronic Myelogenous Leukemia CML 50 germline mutation 50 cancerous breast 50 hemangiomas 50 Osteosarcoma 50 ovarian colon 50 dysglycemia 50 basal cell 50 Squamous 50 Zyclara Cream 50 GBA mutations 50 papillary 50 cancerous colon polyps 50 #q#.# [001] 50 kidney urologic 50 ovarian hormones 50 oophorectomy 50 chronic rhinosinusitis 50 fatty liver disease 50 microvascular complications 50 isoflavones 50 Abdominal aortic aneurysms 50 tyrosine kinase inhibitors 50 histologic subtype 50 herpes zoster 50 asymptomatic 50 myelodysplastic syndrome MDS 50 mitochondrial mutations 50 non Hodgkin lymphomas 50 axillary node dissection 50 TMPRSS2 ERG 50 pCR 50 advanced hepatocellular carcinoma 50 keloids 50 invasive ductal carcinomas 50 pancreas esophagus 50 serrated polyps 50 hypermethylated 50 schwannomas 50 ARVD 50 Folate deficiency 50 histologies 50 Barrett Esophagus 50 gastric pancreatic 50 HGPIN 50 fecal occult blood 50 Menopausal hormone therapy 50 medically inoperable 49 grade serous ovarian 49 Acoustic neuromas 49 GBMs 49 subclinical atherosclerosis 49 Tumors 49 GnRH agonists 49 PTEN mutation 49 heterozygous FH 49 thromboembolic disease 49 Zolinza 49 grade dysplasia 49 T#I mutant 49 hereditary nonpolyposis colorectal cancer 49 Carcinoid tumors 49 PTEN mutations 49 recurrences 49 neuro degenerative disease 49 cervical uterine 49 susceptibility gene 49 solar keratosis 49 bile duct cancers 49 dysplastic lesions 49 microvascular disease 49 genetic syndromes 49 Genital warts 49 colorectal adenocarcinoma 49 node metastases 49 precancerous condition 49 malignant prostate 49 Leukemias 49 systemic lupus erythematosus SLE 49 EGFR 49 metastatic kidney 49 aphthous stomatitis 49 abdominal adiposity 49 Malignant melanoma 49 transitional cell carcinoma 49 idiopathic myelofibrosis 49 ovarian cervical 49 WT1 49 amyloid deposition 49 cutaneous squamous cell carcinoma 49 carcinoma HNSCC 49 Chronic lymphocytic leukemia 49 bone metastases 49 squamous cell carcinoma SCC 49 precancerous cells 49 lymph node biopsies 49 genetic mutation 49 bladder tumors 49 HIV HCV coinfected 49 inherited neurological disorder 49 gliomas 49 enterovirus infection 49 axillary dissection 49 HPV subtypes 49 mutated K ras 49 KRAS oncogene 49 oligodendrogliomas 49 TTR gene 49 congenital anomalies 49 genetic abnormalities 49 coronary artery disease 49 varicella zoster virus 49 GRK5 49 Velculescu 49 malignant lymphoma 49 lobular involution 49 geographic atrophy 49 noncancerous tumors 49 Hurthle cell 49 detecting colorectal cancer 49 HBeAg negative 49 commonest cancers 49 PNET 49 Pancreatic 49 acute myelogenous leukemia AML 49 hyperplastic polyps 49 Gleevec resistant 49 GSTT1 49 de ath 49 pelvic malignancies 49 Polycystic ovary syndrome PCOS 49 lobules 49 presymptomatic 49 apoC III 49 Candida infection 49 SOD1 gene 49 myeloid leukemia 49 cranial irradiation 49 rs# [002] 49 TACI mutations 49 Pap smear screening 49 genetic alterations 49 inherited predisposition 49 cervical precancers 49 cystic lesions 49 herpesviruses 49 endometrioid 49 TCF#L# gene 49 histological subtype 49 melanoma lesions 49 S. aureus isolates 49 Follicular lymphoma 49 Melanoma 49 SPINK1 49 oesophageal 49 antitumor effect 49 melanoma skin 49 Synovial sarcoma 49 PKCi 49 superficial bladder cancer 49 histologic subtypes 49 Epstein Barr Virus 49 colonoscopy screenings 49 intestinal metaplasia 49 chronic periodontitis 49 prostate carcinoma 49 sortilin 49 BRCA gene mutations 49 CMV infections 49 TP# gene 49 Glioma 49 Rhabdomyosarcoma 49 simplex virus 49 chemoradiation 49 pilocytic astrocytomas 49 estrogen progestin therapy 49 recurrent glioblastoma multiforme GBM 49 BCR ABL 49 CT colonography 49 dyskeratosis congenita 49 nonalcoholic steatohepatitis NASH 49 Anaplastic 49 Epidermal Growth Factor Receptor 49 BRCA2 gene 49 tumor suppressors 49 imatinib Gleevec 49 bilateral oophorectomy 49 Enlarged prostate 49 precancerous spots 49 fibrocystic changes 49 Bacterial infection 49 urethritis 49 beta1 integrin 49 IDH2 49 periodontal bacteria 49 Ascherio 49 nestin 49 Rectal cancer 49 HER2/neu 49 polycystic ovarian syndrome PCOS 49 frontotemporal dementia 49 achromatopsia 49 obstructive coronary artery 49 Getzenberg 49 lymphatic cancers 49 Colorectal cancer CRC 49 artery blockages 49 severe oral mucositis 49 oropharyngeal cancers 49 hemorrhagic strokes 49 adjuvant radiation 49 myeloproliferative neoplasms 49 prostate colorectal 49 benign noncancerous 49 Obstructive sleep apnea 49 esophagus colon 49 NOMID 49 colorectal cancer screening 49 ErbB2 positive 49 thrombotic complications 49 refractory CML 49 Oesophageal cancer 49 Colorectal 49 Prostate cancer 49 Folic acid supplements 49 haptoglobin 49 NF2 49 synovial cells 49 HER2 amplification 49 miRNA genes 49 prostate abnormalities 49 Periodontal disease 49 lobular 49 LRAT 49 cervical abnormalities